KÄÄPÄ Biotech, a biotechnology company that researches, innovates and develops functional mushroom products, has announced that the European Food Safety Authority (EFSA) has evaluated and validated their NordRelease™ extraction process for mushroom extracts. This landmark decision justifies the years of research and development by the teams at KÄÄPÄ Biotech to set a new standard of excellence in the functional mushroom and nutraceutical space. It places KÄÄPÄ Biotech as a world leader for bioactive content and quality testing. 

Read the full press release